Standout Papers
Immediate Impact
2 from Science/Nature 70 standout
Citing Papers
Lipoprotein(a) and cardiovascular disease
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Greg Irving being referenced
Behaviour change, weight loss and remission of Type 2 diabetes: a community‐based prospective cohort study
2019
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Greg Irving | 426 | 298 | 227 | 327 | 58 | 1.7k | |
| Robert J. Romanelli | 390 | 218 | 185 | 264 | 76 | 1.7k | |
| Verônica Colpani | 273 | 414 | 368 | 343 | 47 | 2.3k | |
| Susan Lin | 508 | 231 | 257 | 258 | 46 | 1.6k | |
| Germán Málaga | 239 | 269 | 184 | 593 | 110 | 1.8k | |
| Amanda Honeycutt | 526 | 438 | 190 | 558 | 49 | 2.0k | |
| Betsy L. Cadwell | 258 | 462 | 281 | 846 | 42 | 1.9k | |
| Digsu N. Koye | 219 | 420 | 120 | 550 | 44 | 1.7k | |
| John Boscardin | 329 | 439 | 671 | 159 | 74 | 2.2k | |
| Kris Aubrey‐Bassler | 476 | 223 | 240 | 227 | 61 | 1.4k | |
| Mihriye Mete | 230 | 162 | 332 | 480 | 78 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...